Research Material • LY3437943
Retatrutide Research Reference
Retatrutide, also identified in scientific
literature by the development code LY3437943,
is an investigational peptide-based compound. Royal Peptides
supplies Retatrutide in multi-vial research-kit formats for
laboratory, analytical, and scientific research applications.
This page serves as the primary Royal Peptides reference for
Retatrutide research kits, compound identification, available
research quantities, batch traceability, and analytical
documentation.
Retatrutide
LY3437943
10-Vial Research Kits
Batch Traceability
Analytical Documentation
Compound Identity
Retatrutide / LY3437943
Retatrutide is the official name associated with the
investigational compound also referenced as
LY3437943 or LY-3437943
in public scientific and regulatory databases.
Compound identifiers below are provided to help researchers
distinguish Retatrutide from similarly named materials and
locate corresponding scientific records. They describe the
published reference compound and should not be interpreted as
a substitute for lot-specific analytical characterization of
any physical research sample.
Common name
Retatrutide
Development identifier
LY3437943
CAS Registry Number
2381089-83-2
FDA UNII
NOP2Y096GV
Molecular formula*
C221H342N46O68
Published molecular mass*
≈ 4,731 g/mol
Material class
Peptide research material
Royal Peptides format
10-vial research kits
i
*Scientific-reference values:
molecular data shown here refer to the published compound
record and do not constitute batch-specific analytical
verification. Researchers should use documentation
corresponding to the actual production lot when evaluating
a supplied material.
Scientific Context
A Compound Under Active Investigation
Public scientific records describe Retatrutide as an
investigational peptide designed to interact with
GIP, GLP-1, and glucagon receptor systems.
The compound has been investigated within an extensive
clinical-development program and remains an investigational
molecule rather than an approved medicine.
Royal Peptides references this scientific background solely
to establish compound identity and research context. Published
studies involving an investigational molecule do not establish
the composition, identity, purity, performance, or suitability
of a separate commercial research sample.
Compound Identification
Public identifiers such as Retatrutide, LY3437943,
CAS 2381089-83-2, and UNII NOP2Y096GV help establish
a consistent reference to the scientific compound.
Analytical Research
Laboratory evaluation may involve appropriate analytical
techniques selected by qualified researchers according to
the objectives and controls of the research workflow.
Published Literature
Scientific literature may be consulted for historical,
structural, and experimental context concerning the
published Retatrutide reference molecule.
Lot-Specific Evidence
Analytical information relating to a particular physical
sample should be associated with the applicable production
lot rather than inferred from general literature.
Research Kit Format
Retatrutide 10-Vial Research Kits
This product page is dedicated to Royal Peptides
10-vial Retatrutide research kits.
Available kit quantities are presented through the product
variation selector above, allowing laboratories to select the
research quantity appropriate to their procurement
requirements.
A kit variation represents ten vials of the selected nominal
research quantity. The currently available variation list,
pricing, and inventory status shown by WooCommerce should be
treated as the current product record.
One Product, Multiple Variations
Research-kit quantities are organized as variations of
this primary Retatrutide kit product instead of creating
a separate product page for every available quantity.
Kit Identification
Product and batch identification should be retained with
the kit packaging and associated laboratory records.
!
Individual vial labeling may differ from retail single-vial
products. Refer to the product notice displayed above the
long description and retain kit-level product and batch
identification with the material.
Research Procurement Guide
Comparing 10-Vial Kits & Bulk Research Orders
Evaluating larger research quantities? Our 2026 procurement
guide explains the differences between
10-vial peptide kits,
wholesale Retatrutide,
wholesale Tirzepatide, and
100+ vial bulk research orders.
The guide covers unit-cost comparison, price-per-milligram
evaluation, third-party analytical documentation, lot
traceability, U.S. fulfillment, and factors laboratories can
consider when comparing bulk peptide suppliers.
Analytical Documentation
Batch Identification & COA Records
Royal Peptides maintains analytical documentation for
applicable research-material lots. Because analytical results
relate to the material evaluated from a specific production
batch, researchers should match documentation to the
corresponding lot whenever batch-level information is
available.
01 — Identify the Material
Confirm the product name, selected research quantity,
batch or lot reference, and other identifying information
supplied with the research material.
02 — Match the Batch
Use the applicable lot reference to locate corresponding
analytical documentation rather than relying on a report
associated with a different production batch.
03 — Review the Report
Review the analytical methods, reported results,
laboratory information, and sample identifiers contained
in the available documentation.
04 — Preserve Traceability
Retain relevant product, lot, analytical, receipt, and
storage records with the laboratory's internal research
documentation.
Research Traceability
Why Lot-Level Documentation Matters
A scientific publication describes the molecule investigated
by the authors. A database record describes a referenced
chemical or biological entity. Neither independently verifies
the characteristics of a physical vial supplied in a separate
production batch.
For that reason, Royal Peptides distinguishes
compound-reference information from
batch-specific analytical information.
The latter should be used when documenting the actual research
material incorporated into a laboratory workflow.
Compound Identity
Production Lot
Analytical Record
Traceability
Alternative Research Format
Need Individual Retatrutide Vials?
This page covers Royal Peptides
10-vial Retatrutide research kits.
Researchers requiring smaller individual quantities can
review the separate Retatrutide single-vial product.
Keeping the two formats separate provides clearer product
identification while allowing each page to present information
specific to its respective research-material format.
Retatrutide FAQ
Retatrutide Research Questions
What is Retatrutide?
Retatrutide is the official name associated with the
investigational peptide compound also identified as
LY3437943. Royal Peptides supplies a research material
bearing this compound designation exclusively for
laboratory, analytical, and scientific research.
Is LY3437943 the same research identifier associated with Retatrutide?
Yes. LY3437943 and LY-3437943 appear in scientific and
regulatory records as development identifiers associated
with Retatrutide.
What is the CAS number associated with Retatrutide?
The validated NCATS substance record for Retatrutide lists
CAS Registry Number 2381089-83-2. This identifier refers
to the published compound record and does not replace
lot-specific analytical documentation for a supplied
research sample.
What does a Retatrutide kit variation contain?
This product is organized as a 10-vial research-kit
product. Selecting a variation above determines the
nominal research quantity associated with each vial in
that kit. Current variation availability is displayed
directly by the product selector.
Are Retatrutide single vials available separately?
Yes. Royal Peptides maintains a separate Retatrutide
Single Vial product for researchers requiring individual
research quantities rather than the 10-vial kit format.
Is batch-specific analytical documentation available?
Analytical documentation may be available for applicable
production lots. Researchers should use the lot or batch
information associated with the material received to
identify corresponding documentation in the Royal Peptides
COA library.
Why should a COA be matched to a specific lot?
Analytical results describe the sample evaluated by the
testing laboratory. Matching the report to the applicable
production lot helps maintain traceability between the
physical research material and its associated analytical
record.
Is Retatrutide an approved medicine?
No. Retatrutide remains an investigational molecule and
is not an approved medicine. Royal Peptides does not offer
this research material for therapeutic, diagnostic,
clinical, human, or veterinary use.
Does Royal Peptides provide Retatrutide dosing or administration instructions?
No. Royal Peptides does not provide dosing, prescribing,
injection, administration, treatment, or personal-use
instructions for this research material.
Research Use Only
Laboratory Research Material
Royal Peptides Retatrutide is supplied exclusively for
laboratory, analytical, and scientific research purposes.
It is not intended for human or veterinary use, ingestion,
injection, administration, pharmaceutical compounding,
diagnostic use, therapeutic use, clinical use, or personal
experimentation.